SPSantosh Kumar Panda

Santosh Kumar Panda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Santosh Kumar Panda has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Oral Melatonin for Pain Relief During Venepuncture in Neonates– a Pilot Randomized Control Trial

    by Sushree Smita Behura, Santosh Kumar Panda, Subhrajyoti Tripathy, Ipsa Kujur, Swaranjika Sahoo, Deepti Damayanty Pradhan

    Purpose This study aims to compare the analgesic efficacy of oral melatonin with placebo in neonates during venepuncture. Methods This open-level, pilot randomized controlled trial was conducted in a tertiary care neonatal unit. Sixty eligible, non-sick neonates (gestational age ≥ 34 weeks) scheduled for venepuncture were randomized into the melatonin group (MG, n = 30) and the placebo group (PG, n = 30). MG received oral melatonin (1 mg/kg), and PG received 2 ml of normal saline. Pain intensity was measured by the Premature Infant Pain Profile-Revised (PIPP-R) during the procedure and at 1 min and 2 min post-procedure. Scores were compared between both groups using the Mann–Whitney U test, and the effect size was calculated with the rank-biserial correlation coefficient. Results The demographic characteristics were comparable between the two groups. The median (Q1-Q3) PIPP-R score in MG and PG during the procedure was 10 (9–10) and 13 (12–14), respectively, r = 0.8, p < 0.001; at 1 min [3 (2–3) and 5.5 (4–7)], r = 0.69, p < 0.001; and at 2 min [0 (0–0) and 1 (0–2)], r = 0.3, p = 0.003. Melatonin improved autonomic stability during (lower heart rates and higher oxygen saturation) and after venepuncture (higher oxygen saturation). Although procedural facial expressions were similar, fewer neonates in the melatonin group showed pain-related facial cues post-procedure compared to placebo. No significant adverse effect was noted in either group. Conclusion Oral melatonin showed autonomic modulation and reduced PIPP-R scores in neonates during venepuncture compared to placebo, with no adverse effects, supporting its use as an analgesic. Clinical trial registry of India (CTRI) number- CTRI/2023/07/055046 on dated 11.07.2023.


  • Open Access

    Neonatal Anemia in Preterm Infants: Are We Overtransfusing?

    by Pravati Jena, Rojalin Rout, Rama K. Gudu, Deepti D. Pradhan, Santosh Kumar Panda

    Aims and objectives: The purpose of this study was to ascertain the appropriate packed red blood cell transfusion (PRBCT) practice for preterm infants consistent with multiple international guidelines. Method: This retrospective study was conducted at a tertiary care center in India from February 2019 to December 2020. All preterm neonates born at <32 weeks of gestation who received PRBCTs during the study period were included. The hemoglobin (Hb) levels at the time of transfusion were analyzed to assess adherence to the transfusion thresholds recommended by the British Committee for Standards in Haematology (BCSH), Canadian Blood Services (CBS), and the Australian National Blood Authority (ANBA), considering postnatal age and the need for respiratory support. Results: A total of 43 preterm neonates (gestational age, 28.08±1.08 weeks; birth weight, 1,018±0.027 g) received 78 PRBCTs. Specifically, nine (11.5%) PRBCTs were given in the first week, 14 (18%) in the second week, and 55 (70.5%) at three or more weeks of age. Further, nine (11.5%) PRBCTs were given during mechanical ventilation (MV), 49 (63%) with non-invasive ventilation (NIV) or oxygen (O₂) support, and 20 (25.5%) without O₂ support. The appropriateness of all of the PRBCTs per the BCSH, CBS, and ANBA guidelines was 63/78 (80.7%), 58/78 (74.3%), and 78/78 (100%), respectively. Most of the neonates on respiratory support received PRBCTs in a manner consistent with the CBS, BCSH, and ANBA guidelines, whereas most of the neonates not on oxygen (O₂) therapy received PRBCTs for late anemia (at three weeks or more of age) at a higher Hb level than that suggested by the CBS and BCSH guidelines but consistent with the ANBA guidelines. Conclusion: In this transfusion audit study, liberal PRBCT practice was observed for late anemia among stable preterm infants, consistent with the CBS and BCSH blood transfusion guidelines. Hence, there is room for improvement in PRBCT policies in terms of quality-improvement interventions to prevent over-transfusion.

  • Intravenous fluid supplementation in management of severe unconjugated hyperbilirubinemia in preterm neonates-a randomized controlled trial

    by Aradhana, Santosh Kumar Panda, Pravati Jena, Manas Kumar Nayak, Sebaranjan Biswal, Manaswinee Sahoo, Ramakrushna Gudu, Soumini Rath

    The purpose of this study is to evaluate the role of intravenous fluid supplementation in reducing total serum bilirubin (TSB) in preterm neonates with hyperbilirubinemia. In this open-label randomized control trial, a total of 72 preterm neonates with a gestational age of 29–33+6 weeks and a TSB level exceeding 2 mg/dl below the exchange transfusion threshold as per United Kingdom National Institute for Health and Care Excellence (UK-NICE) guidelines were randomized into the fluid supplementation (FS) group and the control group in a ratio of 1:1. Neonates in the FS group received intravenous fluid (5% dextrose on day 2 or N/5 saline with 5% dextrose, amount: 1/4th of total daily fluid intake or maximum 30 ml/kg over 8 h) with phototherapy vs. only phototherapy in the control group. The primary outcome was reduction in TSB level at 6, 18, and 24 h after intervention and duration of phototherapy in FS compared to the control group. The demographic characteristics and mean (SD) TSB levels of enrolled preterm neonates in both groups were comparable. The mean (SD) reduction in TSB level at 6 h in the FS group and the control group were 1.42 (1.19) and 0.32 (0.17), P = 0.001; at 18 h, 2.11 (1.35) and 0.79 (0.25), P = 0.001; and at 24 h, 2.96 (1.41) and 1.56 (0.46), P = 0.001. There was no significant difference in the duration of phototherapy [mean (SD) 44.66(5.45) vs 43.33 (5.93) h, P = 0.32] and cases of hyponatremia [14 (40%) vs 09 (24.3%) P = 0.153] at 24 h between FS and control group. Conclusion: Intravenous fluid supplementation helps in the rapid reduction of TSB levels in preterm neonates with severe hyperbilirubinemia with minimal adverse effects, but does not affect the duration of phototherapy. What is Known: • Extra fluid supplementation has been found helpful in declining total serum bilirubin levels in late preterm and term neonates. What is New: • Extra intravenous fluid supplementation may help in the rapid decline in total serum bilirubin in preterm neonates born with a gestational age of 29–33+6 weeks. • It may be used in the management of severe hyperbilirubinemia in preterm neonates with intensive phototherapy. Trial registration: Clinical trials registry of India, number—CTRI/2024/01/061381 dated on 04.01.2024.


  • The Longitudinal Antibiotic Susceptibility Pattern Among Gram-negative Bacteria Causing Neonatal Sepsis—From an Eastern Indian Tertiary Care Facility

    by Deepti Damayanty Pradhan, Swaranjika Sahoo, Vetsa Snigdha Hasa, Rishabh Pugalia, Santosh Kumar Panda

    The trend of antimicrobial susceptibility of isolated gram-negative bacteria (GNB) causing neonatal sepsis over a span of six years in a tertiary care neonatal unit in eastern India is reported. The GNB microorganism profile had not changed, but the sensitivity to commonly prescribed higher antimicrobial piperacillin and tazobactam (PIP/TZ) (27.7%-11.6%, p = .013), fluoroquinolone (64%-23.3%, p = .001) had significantly declined. The prevalence of multi-drug resistance (MDR) GNB had increased from 40% to 60%. The sensitivity pattern of GNB for various combinations of empirical antimicrobials is also presented.


  • Open Access

    Iron Overload With Erythrocyte Transfusion in Preterm Infants

    by Santosh Kumar Panda, Pravati Jena, Femitha Pournami, Arathy Vijay

  • Open Access

    Lower Hemoglobin Levels as a Risk Factor for the Development of Retinopathy of Prematurity

    by Rama K Gudu, Swaranjika Sahoo, Pravati Jena, Sushree S Behura, Subhadra Priyadarshini, Santosh K Panda

    Background: Retinopathy of prematurity (ROP) is an important cause of visual morbidity among preterm infants. The objective of the study was to assess the relationship between the initial hematological parameters of the complete blood count (CBC) and ROP development in preterm neonates. Method: This retrospective cohort study was conducted in a neonatal intensive care unit in Odisha. The hematological parameters of the CBC conducted within the first 48 hours of age, demographic characteristics, neonatal morbidities, and ROP screening findings of preterm neonates (gestational age 17.3 g/dL. Conclusion: Preterm neonates with a lower level of Hb during the early postnatal days are at higher risk for ROP development and need to be prioritized for screening.